Showing results (621-630 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 14, 2024
Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate CancerPhilip J Saylor, Keisuke Otani, Rene Balza, et al.
JCO Precision Oncology|February 14, 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical EvidenceShukui Qin, Hongming Pan, Jean Frédéric Blanc, et al.
JCO Precision Oncology|February 8, 2024
Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk ClassifiersRyan J Hutten, Bismarck Odei, Skyler B Johnson, et al.
JCO Precision Oncology|April 5, 2024
First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case ReportCamilla O Hoff, Eduardo Andreazza Dal Lago, Juliana Mota Siqueira, et al.
JCO Precision Oncology|April 11, 2024
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1Jun Gong, Alain C Mita, Zihan Wei, et al.
JCO Precision Oncology|April 11, 2024
Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyVaibhav Sahai, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology|April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable AlterationsJoseph J Park, Alec Chu, Jinju Li, et al.
JCO Precision Oncology|February 21, 2024
Targeting All BRAF Alterations: The (Re)-Search ContinuesDeepak Bhamidipati, Andrew Pellatt, Vivek Subbiah
JCO Precision Oncology|February 23, 2024
Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid TumorsChanning J Paller, Hanna Tukachinsky, Alexandra Maertens, et al.
JCO Precision Oncology|January 31, 2024
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to TreatmentAlessandro Russo, Jessica K Lee, Lincoln W Pasquina, et al.
Pageof 140